about
Inferring reasons for the failure of Staphylococcus aureus vaccines in clinical trialsComplete Genome Sequence of Neisseria meningitidis Serogroup B Strain MC58Complete genome sequence and comparative genomic analysis of an emerging human pathogen, serotype V Streptococcus agalactiae.Genome analysis of multiple pathogenic isolates of Streptococcus agalactiae: implications for the microbial "pan-genome"The complete genome sequence of the gram-positive bacterium Bacillus subtilisGroup A Streptococcus produce pilus-like structures containing protective antigens and Lancefield T antigens.CD81 extracellular domain 3D structure: insight into the tetraspanin superfamily structural motifs.Subunit association and conformational flexibility in the head subdomain of human CD81 large extracellular loopGroup B Streptococcus Pullulanase Crystal Structures in the Context of a Novel Strategy for Vaccine DevelopmentExploiting Antigenic Diversity for Vaccine Design: THE CHLAMYDIA ArtJ PARADIGMStructure-based approach to rationally design a chimeric protein for an effective vaccine against Group B Streptococcus infectionsStructural Basis for Group B Streptococcus Pilus 1 Sortases C Regulation and SpecificityStructural and functional characterization of the Staphylococcus aureus virulence factor and vaccine candidate FhuD2Mining the bacterial unknown proteome: identification and characterization of a novel family of highly conserved protective antigens in Staphylococcus aureusGenomic analysis reveals the molecular basis for capsule loss in the group B Streptococcus populationStreptococcus pyogenes SpyCEP influences host-pathogen interactions during infection in a murine air pouch modelSortase A substrate specificity in GBS pilus 2a cell wall anchoringEnvironmental acidification drives S. pyogenes pilus expression and microcolony formation on epithelial cells in a FCT-dependent mannerProteome analysis of Neisseria meningitidis serogroup A.Genomic approach for analysis of surface proteins in Chlamydia pneumoniaeProduction processes of recombinant IL-1 beta from Bacillus subtilis: comparison between intracellular and exocellular expression.GNA33 of Neisseria meningitidis is a lipoprotein required for cell separation, membrane architecture, and virulence.Functional characterization of a newly identified group B Streptococcus pullulanase eliciting antibodies able to prevent alpha-glucans degradation.Protein array profiling of tic patient sera reveals a broad range and enhanced immune response against Group A Streptococcus antigens.Specific involvement of pilus type 2a in biofilm formation in group B Streptococcus.Analysis of two-component systems in group B Streptococcus shows that RgfAC and the novel FspSR modulate virulence and bacterial fitness.Identification of vaccine candidates against serogroup B meningococcus by whole-genome sequencing.SpyAD, a moonlighting protein of group A Streptococcus contributing to bacterial division and host cell adhesion.Antibody-mediated immunity induced by engineered Escherichia coli OMVs carrying heterologous antigens in their lumen.Structure of the type IX group B Streptococcus capsular polysaccharide and its evolutionary relationship with types V and VIIIdentification of a universal Group B streptococcus vaccine by multiple genome screen.Four-component Staphylococcus aureus vaccine 4C-staph enhances Fcγ receptor expression in neutrophils and monocytes and mitigates S. aureus infection in neutropenic mice.Identification of novel genomic islands coding for antigenic pilus-like structures in Streptococcus agalactiae.Understanding the molecular determinants driving the immunological specificity of the protective pilus 2a backbone protein of group B streptococcusProtectome analysis: a new selective bioinformatics tool for bacterial vaccine candidate discovery.Identification of iron-activated and -repressed Fur-dependent genes by transcriptome analysis of Neisseria meningitidis group B.Streptococcus agalactiae capsule polymer length and attachment is determined by the proteins CpsABCD.Transcriptional and proteomic profiles of group B Streptococcus type V reveal potential adherence proteins associated with high-level invasionMF59- and Al(OH)3-Adjuvanted Staphylococcus aureus (4C-Staph) Vaccines Induce Sustained Protective Humoral and Cellular Immune Responses, with a Critical Role for Effector CD4 T Cells at Low Antibody Titers.Multi high-throughput approach for highly selective identification of vaccine candidates: the Group A Streptococcus case.
P50
Q21131308-8CC39814-18D5-45E4-BFC6-D2DF1E161968Q22065549-FECFC3E5-AF4F-4747-A603-BC9AD57DA26DQ22066228-010FF16B-2760-48FA-986A-BDFFC66EBD1AQ22066389-2FD52745-31DC-4484-9114-AED89759DD90Q22122360-199E43F0-4233-465D-B3D2-299B4DA0BBBCQ24534879-5C1A584F-05D2-40D1-BEE7-9F37028B0A10Q27473055-5B41914D-EFBF-42D5-AC19-9967C98E11A2Q27639972-5D802065-2E38-48AC-8388-FA3ED69345F5Q27654484-F174321E-4559-47BE-A02C-FFD8FFA1A30DQ27662913-652C04A5-C4E8-48E7-B3CB-A27D4F581BF5Q27667893-7D783CDB-5083-4DB0-892F-8E834FEDCB01Q27675094-3E1B65C7-9877-41C8-B8AA-D06F83C134D0Q27683127-A79C5ECB-4819-4312-A497-2C64999FC5F5Q27685283-E88B7F1C-A1FB-4F5F-8497-FF260102F262Q28547039-D1D7AE1B-A144-4C53-A0D6-20C64EE9D92DQ28728698-4EB33DC0-43B7-4582-9E89-C15DB9CF12DAQ28744252-D8787B96-FDD5-4C5F-97D1-3C077B8D388AQ28748545-D4AFD8A1-CB80-41B8-AE29-B5F40D4F21AEQ30342988-572C84B2-00CA-46D2-BD48-0093C2847613Q31032708-811B2B37-D1DB-476D-9EF5-8198079EA634Q33189927-1BF182F3-4A31-4738-AD01-8641DEE91143Q33200057-D2EEF8D1-F28A-4F7D-B943-8E744501FC9BQ33386016-3DE5C4E9-730B-450E-82E2-C1F2C2FBE479Q33485221-6DF6BAFE-C19B-49A0-8168-AEEF9CEE171CQ33532629-7671EC0A-4558-4301-9EEA-FDCC2BEEFBB2Q33532629-E537E0B6-0CA9-46AE-932E-FC0A5FD861F2Q33647953-602462BB-E923-4E2C-9016-96B6BF3A9705Q33892877-85F1DB81-D1C8-41CF-B171-B6C28EBAF94FQ33899739-907A26BB-690A-4984-AC90-AA3724BCE391Q34037511-C8FE472C-42CF-4857-914A-1EC00D8F2850Q34141003-42836BF4-930F-4E19-B486-CA42C9B4F78FQ34313096-F85B48E7-4F44-4127-83B7-C19FA84C1828Q34478033-70A097CD-0AAD-40AD-8085-ED7570228E2EQ34545209-3BE223B1-D7F9-485B-B93D-8A0D24F3D40AQ34795406-48931A83-1A90-4CAE-BB55-C13D413A3BACQ35148587-CCCC6C4B-9C54-481B-8ACD-72071A7ADC0EQ35234880-9684B769-F270-474C-99DC-FA25EF6A0092Q35351665-689D9276-E924-414D-81E8-48BF90469F96Q35689489-8889E1DD-0A1F-41A6-8E65-766C1F4D81F0Q36032570-C21EEF61-6647-4972-9FFA-FE0E84142526
P50
description
hulumtues
@sq
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Guido Grandi
@ast
Guido Grandi
@en
Guido Grandi
@es
Guido Grandi
@sl
type
label
Guido Grandi
@ast
Guido Grandi
@en
Guido Grandi
@es
Guido Grandi
@sl
prefLabel
Guido Grandi
@ast
Guido Grandi
@en
Guido Grandi
@es
Guido Grandi
@sl
P106
P1153
7004305689
P2038
Guido_Grandi
P21
P31
P496
0000-0001-9724-2185